Gas-Generating Polymer Micelles for Ultrasound Imaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional microbubble ultrasound contrast agents are unstable in blood circulation and large in size, limiting their use for precise disease diagnosis and bioactive functions, especially in vascular invasion and cancer tissue imaging.
Innovation Solution
Development of gas-generating micelles formed by coupling polyethylene glycol derivatives with alkyl chloroformates, which generate carbon dioxide upon hydrolysis, allowing targeted gas production and enhanced diagnostic imaging capabilities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If microbubbles are used as ultrasound contrast agents, then they can provide contrast imaging, but they are unstable in blood circulation and large in size, limiting their use for precise disease diagnosis
Solution Approach 1:
The invention divides the microbubble structure into separate components: a polymer nanoparticle core containing gas-generating agents (carbonate and carbamate groups) and a shell formed by self-assembled amphiphilic block copolymers. This segmentation allows the gas to be generated in situ from the nanoparticle rather than being pre-formed in a large microbubble structure, achieving both stability and small size for precise targeting.
Solution Approach 2:
The invention changes the physical state and size parameters by transitioning from micrometer-scale microbubbles to nanometer-scale polymer nanoparticles (typically 10-100 nm). This parameter change enables the contrast agent to circulate stably in blood vessels and penetrate into cancer tissues and lymph nodes, overcoming the size limitation of conventional microbubbles.
2Measurement precision
If microbubbles are used for ultrasound imaging, then they can provide contrast, but they have difficulty in disease-specific diagnosis and cancer tissue invasion due to their large size
Solution Approach 1:
The invention introduces ligands (such as antibodies, peptides, or small molecules) onto the surface of the polymer nanoparticle shell, creating local functional regions that specifically recognize and bind to target molecules on cancer cells or in diseased tissues. This local quality enhancement enables disease-specific diagnosis while maintaining the small nanometer-scale size for effective tissue penetration.
3Quantity of substance
If microbubbles are used as contrast agents, then they can provide ultrasound imaging, but they are inherently unstable in the circulation of blood such that the concentration of microbubbles that can reach a site to be diagnosed is low
Solution Approach 1:
The invention creates a composite structure consisting of a polymer nanoparticle core containing gas-generating agents (carbonate and carbamate groups) surrounded by a shell of amphiphilic block copolymers. This composite design provides both colloidal stability for blood circulation and the ability to generate gas in situ, enabling high concentration accumulation at the diagnosis site through stable circulation and targeted retention.
4Reliability
If conventional contrast agents are used, then they can provide imaging, but their toxicity has limited the clinical application
Solution Approach 1:
The invention uses biodegradable polymer materials (such as poly(lactic-co-glycolic acid) or poly(epsilon-caprolactone)) that can be safely metabolized and eliminated from the body. These polymers form temporary nanoparticles that circulate, deliver their gas-generating function, and then degrade into harmless byproducts, providing a safe alternative to toxic conventional contrast agents with repeated use potential.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The gas-generating micelles provide stable, targeted carbon dioxide production for improved ultrasound imaging and potential drug delivery, with enhanced diagnostic accuracy and therapeutic effects.
Implementation Method 1
gas-generating micelles which, unlike conventional microbubble ultrasound contrast agents and gas-loaded ultrasound contrast agents, are circulated in the body and deposited on the disease site to generate carbon dioxide
Data Source
AI summary
The present invention relates to a gas-generating micelle prepared by coupling a polyethylene glycol derivative and an alkyl chloroformate. The gas-generating micelles according to the present invention are circulated in the body and deposited on the disease site to generate carbon dioxide, and thus a more enhanced ultrasonic diagnostic image can be obtained.